Clinical Trials List
2026-03-01 - 2041-12-31
Phase III
Recruiting5
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chun-Hui Lee Division of Hematology & Oncology
- Seu-Chun Yang Division of General Internal Medicine
- 周昀澤 Division of General Internal Medicine
- Po-Lan Su Division of General Internal Medicine
- Chin-Wei Kuo Division of General Internal Medicine
- 蔡政軒 Division of General Internal Medicine
- 林建佑 Division of General Internal Medicine
- Yi-Ting Yen Division of General Surgery
- Shang-Yin Wu Division of Hematology & Oncology
- 黃維立 Division of General Surgery
- 張超群 Division of General Surgery
- Chian-Wei Chen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
38 participants
-
Global
876 participants
